The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
Clinical trial NCT06124794 · COMPLETED
Trial details
- NCT number
- NCT06124794
- Sponsor
- Protox Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-18
- Primary completion
- 2024-02-26
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.